If you have diabetes, regularly monitor your blood sugar levels to keep them within the target range
The FDA determined in February 2025 that the semaglutide shortage had ended, which has implications for the regulatory environment around compounded semaglutide
It is intended for laboratory protocols requiring additional material for repeated analysis, extended project timelines or multiple controlled experimental conditions
Note the dates you started and stopped taking Ozempic, Wegovy, or any related medication, as well as dosage changes over time
An oral tablet formulation of semaglutide to treat type 2 diabetes and reduce blood sugar levels
Semaglutide GLP-1 affects the hypothalamus region of the brain, slowing down how fast the stomach empties and delaying gastric emptying into the intestine